Urokinase Treatment: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Urokinase is a medication used to dissolve blood clots in conditions such as pulmonary embolism, deep vein thrombosis, and other clot-related disorders. It works by breaking down proteins in blood clots, helping restore normal blood flow. Urokinase is typically administered in a hospital setting under close medical supervision. Always consult a healthcare provider before starting or adjusting any treatment. You can also consult one of our providers through telemedicine today.

Names of Medication

US Brand Name: Abbokinase (Urokinase)

The generic name refers to the active ingredient in the medication, while the brand name is given by the manufacturer. In this case, Urokinase is the generic name, and Abbokinase is the brand name.

Pharmacologic Category

Thrombolytic Agents

Fibrinolytics

Urokinase Dosing Guidelines

Urokinase is used to treat various conditions where blood clots are a concern. Dosing varies depending on the specific condition. Always follow your healthcare provider’s instructions and consult them before making any changes to your dose. You can also consult one of our providers through telemedicine for personalized guidance.

Urokinase for Pulmonary Embolism (PE)

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Deep Vein Thrombosis (DVT)

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Myocardial Infarction (Heart Attack)

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Arterial Thrombosis

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Ischemic Stroke

Dose: Not commonly recommended for ischemic stroke; consult your healthcare provider for alternative treatments.

Urokinase for Thrombotic Occlusion (Catheter-Related)

Dose: 5,000-25,000 IU administered directly into the catheter over 1-2 hours.

Urokinase for Peripheral Artery Disease (PAD)

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Catheter Occlusion

Dose: 5,000-25,000 IU administered directly into the catheter over 1-2 hours.

Urokinase for Acute Coronary Syndrome

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Urokinase for Venous Thromboembolism (VTE)

Dose: 4,400 IU/kg IV over 10 minutes, followed by 4,400 IU/kg/hour for 12-24 hours.

Dosage Forms and Strengths

Injection powder for solution: 5,000 IU, 25,000 IU, 50,000 IU, 100,000 IU

Urokinase Administration Guidelines

Urokinase is administered intravenously by a healthcare professional in a hospital or clinical setting. It is typically given as an infusion over a period of time, depending on the condition being treated. Your healthcare provider will monitor you closely during treatment to ensure safety and effectiveness. If you have concerns about Urokinase administration, you can speak with one of our providers via telemedicine for more information.

Urokinase Side Effects and Adverse Reactions

Like all medications, Urokinase can cause side effects. It’s important to be aware of these and contact your healthcare provider if you experience any concerning symptoms. Below are some potential side effects, categorized by how often they occur:

Common Urokinase Side Effects

Bleeding: Urokinase can increase the risk of bleeding, especially at the injection site or in areas where clots have been dissolved.

Low Blood Pressure (Hypotension): Some patients may experience a drop in blood pressure during treatment.

Less Common Urokinase Side Effects

Fever: A mild fever may occur during treatment.

Nausea: Some patients may feel nauseous after receiving Urokinase.

Rare Urokinase Side Effects

Allergic Reactions: Although rare, some patients may experience an allergic reaction, including rash, itching, or difficulty breathing.

Severe Bleeding: In rare cases, severe internal bleeding may occur, requiring immediate medical attention.

Contraindications for Urokinase Therapy

A contraindication is a specific situation or condition where a medication should not be used because it may cause harm. It’s important to know if you have any contraindications before starting Urokinase. Below are situations where Urokinase is contraindicated and why:

Active internal bleeding: Urokinase breaks down blood clots, so if you have active internal bleeding, it could worsen the bleeding.

Recent surgery or trauma: If you’ve had recent surgery or a significant injury, Urokinase could increase the risk of bleeding at the surgical site or injury area.

Severe uncontrolled high blood pressure: High blood pressure increases the risk of bleeding in the brain, and Urokinase could further elevate this risk.

History of stroke (within the last 2 months): If you’ve had a recent stroke, Urokinase could increase the risk of brain bleeding, worsening your condition.

Recent gastrointestinal bleeding: If you’ve had recent bleeding in your stomach or intestines, Urokinase could cause more bleeding in these areas.

Known hypersensitivity to Urokinase: If you are allergic to Urokinase, taking it could cause a severe allergic reaction, which could be life-threatening.

Drug to Drug Interactions

Urokinase can interact with other medications, potentially increasing the risk of bleeding or reducing its effectiveness. It’s important to inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Below are some medications that may interact with Urokinase:

1. Warfarin (Coumadin): Both Urokinase and Warfarin thin the blood, which can significantly raise the risk of severe bleeding.
2. Heparin: Like Urokinase, Heparin prevents blood clots. Using them together increases the likelihood of bleeding complications.
3. Aspirin (Bayer, Ecotrin): Aspirin also prevents blood clots, and taking it alongside Urokinase can further elevate the risk of bleeding.
4. Clopidogrel (Plavix): This antiplatelet medication can increase the risk of bleeding when used in combination with Urokinase.
5. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen (Advil) or Naproxen (Aleve): These medications can also heighten the risk of bleeding when taken with Urokinase.

Urokinase in Pregnancy

Is it safe to take Urokinase during pregnancy?

There is limited information regarding the safety of Urokinase use during pregnancy. It should only be considered if the potential benefits outweigh the risks. Your healthcare provider will carefully evaluate your situation to determine whether Urokinase is appropriate for you. If you are pregnant or planning to become pregnant, consult with your healthcare provider or schedule a telemedicine appointment to discuss the best course of action.

Urokinase while Breastfeeding

Is it safe to take Urokinase while breastfeeding?

Currently, there is not enough data to determine whether Urokinase passes into breast milk or if it could affect a nursing infant. If you are breastfeeding or planning to breastfeed, it’s essential to discuss this with your healthcare provider. They will help you weigh the potential risks and benefits of using Urokinase while breastfeeding. Consider scheduling a telemedicine visit to explore your options in more detail.

Estimated Cost of Urokinase Treatment

The cost of Urokinase can vary depending on the pharmacy and your location. Without insurance, the estimated cost for a 30-day supply using a GoodRx coupon ranges from $1,500 to $2,000. It’s a good idea to check with your pharmacy for the most accurate pricing and to explore any available financial assistance programs that may help reduce costs.

Possible Alternatives to Urokinase

If Urokinase is not suitable for you, there are alternative treatments and lifestyle changes that may help manage your condition. Always discuss these alternatives with your healthcare provider before making any changes to your treatment plan. Below are some potential alternatives for specific conditions:

1. Pulmonary embolism: Alternatives include anticoagulants like Heparin or Warfarin, or newer agents such as Apixaban (Eliquis) or Rivaroxaban (Xarelto). In some cases, surgical removal of the clot may be considered.
2. Deep vein thrombosis (DVT): Common treatments include anticoagulants like Enoxaparin (Lovenox) or Warfarin. Compression stockings and regular physical activity can also help prevent DVT.
3. Myocardial infarction (heart attack): Alternatives include medications such as Aspirin, Beta-blockers, or Nitroglycerin. Lifestyle changes, including quitting smoking, adopting a heart-healthy diet, and engaging in regular exercise, are also crucial.
4. Arterial thrombosis: Antiplatelet drugs like Clopidogrel (Plavix) or Aspirin may be used. In some cases, surgery or angioplasty may be necessary to restore blood flow.
5. Ischemic stroke: Thrombolytic agents like Alteplase (tPA) are often used. Antiplatelet drugs and lifestyle changes, such as managing blood pressure and cholesterol, can also help reduce the risk of future strokes.
6. Thrombotic occlusion: Anticoagulants or thrombolytic agents may be used. In some cases, a procedure to remove the clot may be necessary.
7. Peripheral artery disease (PAD): Medications like Cilostazol (Pletal) or Aspirin can help manage symptoms. Lifestyle changes, such as quitting smoking and increasing physical activity, are also important.
8. Catheter occlusion: Alternatives include using Heparin or Alteplase to clear the catheter. In some cases, the catheter may need to be replaced.
9. Acute coronary syndrome: Treatments include Aspirin, Nitroglycerin, and Beta-blockers. In some cases, angioplasty or surgery may be required.
10. Venous thromboembolism (VTE): Anticoagulants like Apixaban (Eliquis) or Rivaroxaban (Xarelto) are commonly used. Compression stockings and regular physical activity can also help prevent VTE.

Recent Updates on Urokinase Research

Recent studies have focused on improving the safety and effectiveness of Urokinase, particularly in patients with complex conditions such as pulmonary embolism and deep vein thrombosis. Researchers are also exploring new methods of administering Urokinase to reduce the risk of bleeding. Additionally, ongoing research is investigating synthetic alternatives to Urokinase that may offer similar benefits with fewer side effects. As more studies are completed, we will continue to update this information to ensure you have the most accurate and up-to-date details. If you have any questions about the latest research or how it may impact your treatment, consider scheduling a telemedicine appointment with one of our providers.

James Kingsley

Learn More